Literature DB >> 25466348

A new era of drug therapy for idiopathic pulmonary fibrosis.

Michael G Crooks1, Simon P Hart2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25466348     DOI： 10.1016/S2213-2600(14)70257-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

Review 1.  Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.